Covid-19 vaccine-related adverse effects and perceptions in Haryana State of India
Bibliographic Data
| ID | 15799705 |
|---|---|
| Authors | Kamal Kamal (0000-0002-6110-4490, Kurukshetra University, corresponding author), Themba Andile Msibi (Kurukshetra University) |
| Year | 2022 |
| Pages | 1579-1610 |
| Publication date | 2022-06-15 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Health Sciences (JOURNAL) |
| Journal identifiers | ISSN: 2550-696X • E-ISSN: 2550-6978 |
| Publisher | Universidad Tecnica de Manabi (PUBLISHER • EC) |
| DOI | 10.53730/ijhs.v6ns5.9008 |
| OpenAlex | W4283451326 |
| Language | EN |
| References cited | 6 |
Background: The focus of this study was on any COVID-19 vaccines adverse effects, as well as perceptions about the vaccines. Among many, Covishield Covid-19 (ChAdOx1 nCoV-19) and Covaxin COVID-19 (BBV152) vaccines are some of the vaccines which have reached their advanced stages. These two brands are very common in India, and the majority of the already vaccinated populations in India comes from these two brands. Methods: It was a quantitative systemic randomized retrospective cohort kind of a study where only healthcare practitioners were targeted, especially the prescribers. Survey questionnaire was used as a tool of collecting the data from the voluntarily recruited participants. Results: Among the participants, males (106) were more than females (98). Different healthcare professionals: 100 (49.0%) were Physician/doctors; 36 (17.6%) were Pharmacists; 27 (13.2%) were Nurses; 23 (11.3%) were Medical Lab. Technicians and 18 (8.8%) were others. 123 participants reported not been affected by any side effects after taking the COVID-19 vaccines, in contrast, 81 participants reported to have experienced adverse effects after had taken the vaccines. Conclusion: This study showed that post-vaccination, of both first and second dose, adverse effects were mild to moderate, non-serious and non-life threatening
Adverse effect · Coronavirus disease 2019 (COVID-19 · Disease · Family medicine · Health care · Vaccination · Diverse Scientific Research Studies · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Immunology · Internal Medicine
The epidemiology and pathogenesis of coronavirus disease (Covid-19) outbreak
Sars-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Genomic characterisation and epidemiology of 2019 novel coronavirus
Covid-19 pandemic – an African perspective
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Covid-19 Vaccines Safety Tracking (CoVaST)
| Citation velocity | historical |
|---|---|
| Highly cited | No |